2024
DOI: 10.3390/life14010114
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Blood-Count-Derived Inflammatory Markers in Psoriatic Disease Progression

Oana Mirela Tiucă,
Silviu Horia Morariu,
Claudia Raluca Mariean
et al.

Abstract: Psoriasis is a chronic immune-mediated disease, linked to local and systemic inflammation and predisposing patients to a higher risk of associated comorbidities. Cytokine levels are not widely available for disease progression monitoring due to high costs. Validated low-cost and reliable markers are needed for assessing disease progression and outcome. This study aims to assess the reliability of blood-count-derived inflammatory markers as disease predictors and to identify prognostic factors for disease sever… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 45 publications
0
1
0
Order By: Relevance
“…Moreover, it has been discovered that the mean SII was lower in the patients receiving biologic treatment compared to the untreated patients ( 33 , 34 ). According to an observational retrospective study, SII was positively correlated with disease severity and was an independent prognostic factor for mild and moderate psoriasis ( 35 ).…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, it has been discovered that the mean SII was lower in the patients receiving biologic treatment compared to the untreated patients ( 33 , 34 ). According to an observational retrospective study, SII was positively correlated with disease severity and was an independent prognostic factor for mild and moderate psoriasis ( 35 ).…”
Section: Discussionmentioning
confidence: 99%